Related Experiment Video

Updated: Aug 10, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

[Fulminant mycoplasma pneumoniae infection presenting with Stevens-Johnson syndrome & respiratory failure]

T Shirai1, A Sato, A Okano

  • 1Second Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|October 1, 1991
PubMed

Insights

A rare case of severe Mycoplasma pneumoniae infection presented with Stevens-Johnson syndrome and respiratory failure. This fulminant infection led to multiple extra-pulmonary complications and ultimately, death despite intensive medical intervention.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Dermatology

Background:

  • Stevens-Johnson syndrome is a severe mucocutaneous reaction, often triggered by infections or medications.
  • Mycoplasma pneumoniae is a common cause of respiratory infections, but severe systemic complications are rare.

Observation:

  • An 18-year-old male presented with symptoms consistent with SJS, including fever, rash, conjunctivitis, cough, and dyspnea.
  • Despite initial treatment for SJS and pneumonia, the patient's condition rapidly deteriorated, with progression of lung infiltrates and development of jaundice, sepsis, and emphysema.
  • Postmortem lung examination revealed diffuse alveolar damage.

Findings:

  • Complement-fixation titers confirmed a significant rise in Mycoplasma pneumoniae antibodies.
  • The clinical presentation and autopsy findings were attributed to a fulminant Mycoplasma pneumoniae infection complicated by SJS-like symptoms and multi-organ failure.

Implications:

  • This case underscores the importance of considering Mycoplasma pneumoniae as a potential cause of severe mucocutaneous reactions and fulminant respiratory failure.
  • Early recognition and specific treatment for Mycoplasma pneumoniae may be crucial in preventing severe outcomes.
  • Further research into the immunopathogenesis of Mycoplasma pneumoniae-induced SJS is warranted.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...